A salt of an apoptosis signal-regulating kinase 1 inhibitor and a crystal form thereof. Specifically, the present invention relates to an acid addition salt of a compound represented by general formula (I), a crystal form thereof, a preparation method therefor and an application thereof, as well as a pharmaceutical composition containing a therapeutically effective amount of the salt.